Image of Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer (Review)

LITERATURE

Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer (Review)


Retrospective analyses suggest that capecitabine may carry superior activity in hormone receptor-positive relative to hormone receptornegative
metastatic breast cancer. This review examined the veracity of that finding and explored whether this diJerential activity extends
to early breast cancer


Availability

Binecap-006Available

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Cochrane Database of Systematic Reviews 2021, Issue 5. Art. No.: CD011220
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous